Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
Sven Cleeves *Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Member of Fraunhofer International Consortium for Anti-Infective Research (iCAIR), Hannover, Germany.ORCID 0009-0001-1993-0975
Isabel Ramón RothInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-2768-9736
Timm FiebigInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-2021-7296
Thomas VeInstitute for Glycomics, Gold Coast Campus, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0002-0113-1905
Susanne HäusslerDepartment of Molecular Bacteriology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0001-6141-9102
Armin BraunFraunhofer Institute for Toxicology and Experimental Medicine ITEM, Member of Fraunhofer International Consortium for Anti-Infective Research (iCAIR), Hannover, Germany.ORCID 0000-0002-1142-1463
Mark von ItzsteinInstitute for Glycomics, Gold Coast Campus, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0001-6302-7524
Jana I FühringInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-7174-0442
Griffith University · AUMedizinische Hochschule Hannover · DECopenhagen University Hospital · DKFraunhofer Institute for Toxicology and Experimental Medicine · DE
Funding
Department of Education and Training | Australian Research Council (ARC) DE170100783Department of Education and Training | Australian Research Council (ARC) FT200100572Deutsche Forschungsgemeinschaft (DFG) EXC 2155 390874280DHAC | National Health and Medical Research Council (NHMRC) 1157150DHAC | National Health and Medical Research Council (NHMRC) 1196520DHAC | National Health and Medical Research Council (NHMRC) 2009677Novo Nordisk Fonden (NNF) NNF 18OC0033946
6 · The paper itself
Abstract
Multidrug-resistant bacteria such as the opportunistic pathogen
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Tetramerization is essential for the enzymatic function of the · full record | OpenQuestion